Virica Biotech Graduates from Invest Ottawa Accelerator Program

Ontario Industry UpdatesOBIO News
Written By Arsheen Kaur

Invest Ottawa (IO) recently announced its next graduate from the IO Accelerator program, Virica Biotech. The program is designed to use a phased and milestone-based approach to help entrepreneurs grow and scale on their Venture Path. Virica Biotech, a leading innovator in viral enhancement solutions for the biopharmaceutical industry, is the 11th successful graduate from the flagship program.

Virica Biotech is an OBIO® member, an alumnus of our BDSP™ and WiHI programs, and presented at the OBIO® Investment Summit.

Arsheen Kaur
Previous

Aspect Biosystems Announces $200 Million Partnership with the Governments of Canada & BC
Next

Roga Secures $1.7 Million CAD to Reduce Stress and Burnout with its Nerve-Stimulating Website